Hildegard Greinix

Professor Hildegard Greinix received one of the first AA&MDSIF “New Researcher” research grant awards in 1989 while she was a research fellow in experimental and clinical marrow transplantation at the Fred Hutchinson Cancer Research Center in Seattle, Washington. She explained that her grant research “enabled me to work on a large animal model exploring the role of certain HLA antigens in the development of bone marrow failure. The results were published in the well-known peer-reviewed journal Blood and led to further research to explore ways of therapeutic intervention.”

Professor Greinix has had more than 200 publications in well-known peer-reviewed scientific journals over the past 25 years since receiving her AA&MDSIF grant. Her particular research interests include chronic graft-versus-host-disease (GVHD), its diagnosis, predictive biomarkers and treatment strategies. She has extensive experience in performing retrospective and prospective clinical studies in patients with GVHD and is a member of several international research advisory boards. Professor Greinix is an assigned expert for the Austrian Government to the European Commission's directives on stem cells and tissues and she has been an active participant in the NIH Consensus Development Project on Chronic GvHD and a leading expert on diagnosis and staging of chronic GvHD according to the new NIH-defined criteria.